Cormorant Asset Management LP 13D and 13G filings for Praxis Precision Medicines, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 3:03 pm Purchase |
2024-12-31 | 13G | Praxis Precision Medicines, Inc. PRAX |
Cormorant Asset Management LP | 1,693,219 9.080% |
553,219 (+48.53%) |
Filing |
| 2024-11-14 3:08 pm Purchase |
2024-09-30 | 13G | Praxis Precision Medicines, Inc. PRAX |
Cormorant Asset Management LP | 1,140,000 4.670% |
506,655 (+80.00%) |
Filing |
| 2024-02-14 3:05 pm Purchase |
2023-12-31 | 13G | Praxis Precision Medicines, Inc. PRAX |
Cormorant Asset Management LP | 633,345 7.390% |
633,345 (New Position) |
Filing |